21 (R) argatroban intravenous injection containing acid as solubiliser
A technology for intravenous injection and solubilizer, applied in the field of medicine, can solve the problems of extreme instability of light and heat, and achieve the effect of avoiding hydrolysis degradation and other chemical reactions and enhancing infusion characteristics.
Inactive Publication Date: 2011-11-02
TIANJIN WEIJIE TECH
View PDF3 Cites 4 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0005] However, since the solubility of 21(R) Argatroban in water is less than 0.04mg / mL, it is very slightly soluble according to the solute classification of the United States Pharmacopoeia, and it is extremely unstable to light and heat. Therefore, the study of 21(R) Argatroban Addatroban preparations, and its successful clinical use is of great significance
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0014] Embodiment 1: 21 (R) argatroban intravenous injection
[0015]
Embodiment 2
[0016] Embodiment 2: 21 (R) argatroban intravenous injection
[0017]
Embodiment 3
[0018] Embodiment 3: 21 (R) argatroban intravenous injection
[0019]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention discloses a 21 (R) argatroban intravenous injection containing at least one acid as a solubiliser. The intravenous injection is characterized in that at least one acid is utilized for improving the dissolvability of 21 (R) argatroban; at least one buffering agent is utilized for maintaining pH; and at least one penetration regulator is utilized for enhancing transfusion characteristics. A test result shows that the intravenous injection can avoid effectively hydrolysis and other chemical reactions, can be stored stably under light and heat conditions, and can be preserved at room temperature for at least 24 month.
Description
technical field [0001] The invention belongs to the field of medicine, in particular to a thrombin inhibitor using acid as a solubilizing agent. Background technique [0002] Argatroban has been widely used clinically as a thrombin inhibitor, and its chemical name is (2R,4R)-4-methyl-1-[N2-((R,S)-3-methyl-1 , 2,3,4-Tetrahydro-8-quinolinesulfonyl)-L-arginyl]-2-piperidinecarboxylic acid-hydrate [141396-28-3]. The clinically used argatroban is a mixture of two diastereoisomers, 21 (S) and 21 (R), and the drug standard stipulates that the ratio of the two is 65: 35 ± 2. The chemical structural formula of the drug is as follows: [0003] [0004] The chemical name of 21(R) argatroban is (2R, 4R)-4-methyl-1-[N 2 -[(R)-3-Methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl]-L-arginyl]-2-piperidinecarboxylic acid [121785-72-6]. Preliminary animal experiments have proved that the activity of 21(R) argatroban in inhibiting thrombin is higher than that of the blank control group, so 21(...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): A61K38/05A61K47/04A61K47/12A61K47/16A61K47/26A61P7/02
Inventor 宋洪海张冉高巨孙致远孔霞
Owner TIANJIN WEIJIE TECH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com